GRCE Grace Therapeutics, Inc.
Price Chart
Executive Summary
Grace Therapeutics filed an 8-K announcing the departure of Carrie DAndrea as VP of Clinical Operations effective June 5, 2026. She transitioned to a 12-month consulting role at $250/hour with continued stock option vesting. This is a routine officer departure with a pre-arranged consulting transition — no red flags or unexpected C-suite exits.
Actionable Insight
Routine officer departure with consulting bridge — no immediate trading signal. Monitor next filing for the separation agreement to confirm severance terms, but no material impact expected.
Key Facts
- Carrie DAndrea ceased as VP of Clinical Operations effective June 5, 2026
- Approved by the Company on June 1, 2026
- Ms. DAndrea entered into a 12-month Consulting Agreement with a fee of $250 per hour
- Stock option awards will continue to vest during the consulting term
- Consulting covers clinical development and NDA-related activities
- Separation agreement not yet executed; will be filed separately
Financial Impact
Not specified
Market Snapshot
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001140361-26-024269 |
| Document: ef20075612_8k.htm | 0001140361-26-024269 |
| Document: 0001140361-26-024269-index-headers.html | 0001140361-26-024269 |
| Document: 0001140361-26-024269-index.html | 0001140361-26-024269 |
| Document: 0001140361-26-024269.txt | 0001140361-26-024269 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 5, 2026
7d ago
|
8-K
| $2.38 awaiting T+20 | awaiting T+20 | — | $2.20 (−7.56%) |
|
Apr 27, 2026
6w ago
|
8-K
| $2.16 $2.36 | ▼ −9.26% | ▼ −4.30% | $2.20 (−1.85%) |
|
Apr 23, 2026
7w ago
|
8-K
| $2.35 $2.18 | ▲ +7.23% | ▲ +11.87% | $2.20 (+6.38%) |
|
Apr 14, 2026
8w ago
|
Press Release
| $4.28 $2.35 | ▼ −45.09% | ▼ −51.39% | $2.20 (−48.60%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access